<PubmedArticle>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">25426410</PMID>
<DateCompleted>
<Year>2014</Year>
<Month>11</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Print">2211-338X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>9</Volume>
<PubDate>
<Year>2014</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Gynecologic oncology case reports</Title>
<ISOAbbreviation>Gynecol Oncol Case Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>Hyperthermic Intra-Thoracic Chemotherapy (HITeC) for the management of recurrent ovarian cancer involving the pleural cavity.</ArticleTitle>
<Pagination>
<MedlinePgn>24-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gynor.2014.05.001</ELocationID>
<Abstract>
<AbstractText>•Intra-thoracic chemotherapy is an option for heavily pre-treated patients with recurrent ovarian cancer.•HITeC is technically feasible and well tolerated. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Seidman Cancer Center, Cleveland, OH, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Armstrong</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Seidman Cancer Center, 11100 Euclid Ave, Cleveland, OH 44106, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Robke</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Seidman Cancer Center, Cleveland, OH, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Waggoner</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Seidman Cancer Center, Cleveland, OH, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Debernardo</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Cleveland Clinic Foundation, Cleveland, OH, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>05</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Gynecol Oncol Case Rep</MedlineTA>
<NlmUniqueID>101599306</NlmUniqueID>
<ISSNLinking>2211-338X</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Intra-thoracic chemotherapy</Keyword>
<Keyword MajorTopicYN="N">Ovarian cancer</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2014</Year>
<Month>04</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2014</Year>
<Month>05</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>11</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>11</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>11</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">25426410</ArticleId>
<ArticleId IdType="doi">10.1016/j.gynor.2014.05.001</ArticleId>
<ArticleId IdType="pii">S2211-338X(14)00016-7</ArticleId>
<ArticleId IdType="pmc">PMC4241480</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Cancer Res Clin Oncol. 2009 Dec;135(12):1637-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19701772</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gynecol Oncol. 2012 Sep;126(3):397-402</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22613353</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer. 2006 May 1;106(9):1933-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16572412</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1996 Dec 26;335(26):1950-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8960474</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2006 Jan 5;354(1):34-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16394300</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Oncol. 2009 Apr;36(2):106-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19332245</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gynecol Oncol. 2012 Dec;127(3):502-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23022234</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2002 Mar 1;20(5):1248-59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11870167</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Oncol. 2001 Feb 15;19(4):1001-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11181662</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>